1.Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis.
Yeon Sik HONG ; Su Jin MOON ; Young Bin JOO ; Chan Hong JEON ; Mi La CHO ; Ji Hyeon JU ; Hye Jwa OH ; Yu Jung HEO ; Sung Hwan PARK ; Ho Youn KIM ; Jun Ki MIN
Journal of Korean Medical Science 2011;26(9):1132-1139
The interleukin-33 (IL-33)/ST2 pathway has emerged as an intercellular signaling system that participates in antigen-allergen response, autoimmunity and fibrosis. It has been suggested that IL-33/ST2 signaling has been involved in the pathogenesis of rheumatoid arthritis (RA), because IL-33 and its receptor have been specifically mapped to RA synovium. The aim of this study was to determine the levels of IL-33 and sST2 in sera and synovial fluids in patients with RA. The serum level of IL-33 was significantly higher in patients with RA (294.9 +/- 464.0 pg/mL) than in healthy controls (96.0 +/- 236.9 pg/mL, P = 0.002). The synovial fluid level of IL-33 was significantly higher in RA patients than in osteoarthritis patients. The level of serum sST2 was higher in RA patients than in healthy controls (P = 0.042). A significant relationship was found between the levels of IL-33 and IL-1beta (r = 0.311, P = 0.005), and IL-33 and IL-6 (r = 0.264, P = 0.017) in 81 RA patients. The levels of IL-33, sST2 and C-reactive protein decreased after conventional disease-modifying antirheumatic drugs treatment in 10 patients with treatment-naive RA. Conclusively, IL-33 is involved in the pathogenesis of RA and may reflect the degree of inflammation in patients with RA.
Adult
;
Aged
;
Antirheumatic Agents/therapeutic use
;
Arthritis, Rheumatoid/blood/drug therapy/*pathology
;
C-Reactive Protein/analysis
;
Female
;
Humans
;
Interleukin-1beta/analysis/blood
;
Interleukin-6/analysis/blood
;
Interleukins/*analysis/blood
;
Male
;
Middle Aged
;
Osteoarthritis/blood/pathology
;
Receptors, Cell Surface/*analysis/blood
;
Synovial Fluid/metabolism
2.Effect of Therapeutic Hypercapnia on Systemic Inflammatory Responses in Hemorrhagic Shock in Rats.
Kyeong Won KANG ; You Hwan JO ; Kyuseok KIM ; Jae Hyuk LEE ; Joong Eui RHEE
Journal of the Korean Society of Traumatology 2012;25(1):17-24
PURPOSE: This study was performed to investigate whether therapeutic hypercapnia could attenuate systemic inflammatory responses in hemorrhagic shock in rats. METHODS: Male Sprague-Dawley rats were mechanically ventilated and underwent pressure-controlled (mean arterial pressure: 38+/-1 mmHg) hemorrhagic shock. At 10 minutes after the induction of hemorrhagic shock, the rats were divided into the normocapnia (PaCO2=35-45 mmHg, n=10) and the hypercapnia (PaCO2=60-70 mmHg) groups. The PaCO2 concentration was adjusted by using the concentration of inhaled CO2 gas. After 90 minutes of hemorrhagic shock, rats were resuscitated with shed blood for 10 minutes and were observed for 2 hours. The mean arterial pressure (MAP) and the heart rate were monitored continuously, and the results of arterial blood gas analyses, as well as the plasma concentrations of interleukin (IL)-6, IL-10, and nitrite/nitrate were compared between the normocapnia and the hypercapnia groups. RESULTS: The MAP and the heart rate were not different between the two groups. The plasma concentration of IL-6 was significantly lower in the hypercapnia group than in the normocapnia group (p<0.05). The IL-10 concentration was not different and the IL-6 to IL-10 ratio was significantly lower in the hypercapnia group compared to the normocapnia group. The plasma nitrite/nitrate concentration of the hypercapnia group was lower than that of the normocapnia group. CONCLUSION: Therapeutic hypercapnia attenuates systemic inflammatory responses in hemorrhagic shock.
Animals
;
Arterial Pressure
;
Blood Gas Analysis
;
Cytokines
;
Heart Rate
;
Humans
;
Hypercapnia
;
Inflammation
;
Interleukin-10
;
Interleukin-6
;
Interleukins
;
Male
;
Nitric Oxide
;
Plasma
;
Rats
;
Rats, Sprague-Dawley
;
Shock, Hemorrhagic
3.Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease.
Dae Jun KIM ; Seung Ye BAEK ; Mi Kyung PARK ; Kyung Su PARK ; Jae Ho LEE ; Sung Hwan PARK ; Ho Youn KIM ; Seung Ki KWOK
Journal of Korean Medical Science 2013;28(8):1145-1153
Interleukin (IL)-33 is an important mediator of innate immunity. Behcet's disease (BD) is an autoinflammatory disorder characterized by hyperactivity of the innate immune response. We measured serum levels of IL-33 and its receptor soluble ST2 (sST2) in patients with BD to investigate their association with disease activity. Serum levels of both IL-33 and sST2 were higher in patients with BD compared with those in normal controls (IL-33: 594.48+/-175.04 pg/mL in BD and 224.23+/-56.64 pg/mL in normal controls [P=0.048], sST2: 99.01+/-15.92 pg/mL in BD and 23.56+/-3.25 pg/mL in normal controls [P<0.001]). IL-33 and sST2 expression in skin tissue, as shown by immunohistochemistry, was higher in patients with BD compared with that in the normal controls. Serum sST2 level correlated significantly with the BD currently active form (BDCAF), Iranian BD dynamic activity measure (IBDDAM), erythrocyte sedimentation rate and C-reactive protein. Multiple linear regression showed that serum sST2 was an independent factor associated with IBBDAM (regression coefficient, 0.374; P=0.004), and BDCAF (regression coefficient, 0.236; P=0.047). These results demonstrate that IL-33 and sST2 are highly expressed in patients with BD and that serum sST2 is an independent factor associated with IBDDAM and BDCAF, suggesting a potential role for sST2 as a surrogate marker of disease activity in patients with BD.
Adult
;
Behcet Syndrome/blood/*pathology
;
Blood Sedimentation
;
C-Reactive Protein/analysis
;
Female
;
Humans
;
Immunohistochemistry
;
Interleukins/*blood/metabolism
;
Male
;
Middle Aged
;
Receptors, Cell Surface/*blood/metabolism
;
Severity of Illness Index
;
Skin/metabolism/pathology
4.Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients.
Won Ha LEE ; Yoon LEE ; Jong Ran KIM ; Jin A CHU ; Sung Youn LEE ; Jin Ok JUNG ; Joon Soo KIM ; Seonwoo KIM ; Jung Don SEO ; Sung S RHEE ; Jeong Euy PARK
Experimental & Molecular Medicine 1999;31(3):159-164
Inflammation and activation of immune cells have important roles in the pathogenesis of atherosclerosis. We analyzed the plasma levels of inflammatory markers and the degree of activation of peripheral blood monocytes and T-lymphocytes isolated from 12 unstable angina, 12 stable angina, and 12 normal subjects. In 20%-33% of patients, monocytes expressed high basal levels of IL-8, tissue factor, IL-1beta, and monocyte chemoattractant protein-1 mRNA. Furthermore, basal mRNA levels of these cytokines showed strong correlation with each other (p < 0.01 in all combination) but not with tumor necrosis factor-alpha or transforming growth factor-beta1. Plasma level of C-reactive protein was highest in the unstable angina patients (1.63+/-0.70 mg/l) and lowest in the control subjects (0.22+/-0.08 mg/l) (P = 0.03). We also observed a high correlation between C-reactive protein level and the occurrence of minor and major coronary events during 6 months of follow-up. Activation status of T-cells, assessed by the percentage of HLA-DR positive cells, was highest in the unstable angina patients (26.8+/-1.4%) compared with that in the control (14.7+/-1.2%) (P = 0.0053). Our data represent the first case showing that the circulating monocytes in angina patients are activated to a state express numerous proatherogenic cytokines. These results may help to diagnose angina patients according to the inflammatory markers and evaluate the prognosis of the disease.
Aged
;
Angina Pectoris/immunology*
;
Angina Pectoris/diagnosis
;
Angina, Unstable/immunology*
;
Angina, Unstable/diagnosis
;
Biological Markers/blood
;
C-Reactive Protein/analysis
;
Cytokines/blood*
;
Female
;
HLA-DR Antigens/immunology
;
Human
;
Interleukins/blood
;
Lymphocyte Transformation
;
Male
;
Middle Age
;
Monocyte Chemoattractant Protein-1/blood
;
Monocytes/metabolism*
;
RNA, Messenger/metabolism
;
T-Lymphocytes/metabolism*
;
Transforming Growth Factor beta/analysis
;
Tumor Necrosis Factor/analysis
5.Association between Elevated Pleural Interleukin-33 Levels and Tuberculous Pleurisy.
Koung Sun LEE ; Hak Ryul KIM ; Seongae KWAK ; Keum Ha CHOI ; Ji Hyun CHO ; Young Jin LEE ; Mi Kyung LEE ; Jea Hoon LEE ; Seok Don PARK ; Do Sim PARK
Annals of Laboratory Medicine 2013;33(1):45-51
BACKGROUND: Interferon-gamma (IFN-gamma) plays a crucial role in Mycobacterium tuberculosis induced pleural responses. Interleukin (IL)-33 up-regulates the production of IFN-gamma. We aimed to identify whether an association between pleural IL-33 levels and tuberculous pleurisy exists and determine its diagnostic value. METHODS: Pleural IL-33, ST2 (a receptor of IL-33), adenosine deaminase (ADA), and IFN-gamma, as well as serum IL-33 and ST2 were measured in 220 patients with pleural effusions (PEs). Patients with malignant (MPEs), parapneumonic (PPEs), tuberculous (TPEs), and cardiogenic (CPEs) pleural effusions were included. RESULTS: Pleural and serum IL-33 levels were highest or tended to be higher in patients with TPEs than in those with other types of PEs. The median pleural fluid-to-serum IL-33 ratio was higher in TPE cases (> or = 0.91) than in other PE cases (< or = 0.56). Pleural IL-33 levels correlated with those of pleural ADA and IFN-gamma. However, the diagnostic accuracies of pleural IL-33 (0.74) and pleural fluid-to-serum IL-33 ratio (0.75) were lower than that of ADA (0.95) or IFN-gamma (0.97). Pleural ST2 levels in patients with MPEs were higher than in patients with TPEs. Serum ST2 levels did not differ among the groups. CONCLUSIONS: We identified an association between elevated pleural IL-33 levels and tuberculous pleurisy. However, we recommend conventional pleural markers (ADA or IFN-gamma) as diagnostic markers of TPE.
Adenosine Deaminase/analysis
;
Adult
;
Aged
;
Aged, 80 and over
;
Area Under Curve
;
Case-Control Studies
;
Cross-Sectional Studies
;
Female
;
Humans
;
Interferon-gamma/analysis
;
Interleukins/*analysis/blood
;
Male
;
Middle Aged
;
Pleural Cavity/*metabolism
;
Pleural Effusion/diagnosis/metabolism
;
Pleural Effusion, Malignant/diagnosis/metabolism
;
ROC Curve
;
Receptors, Cell Surface/analysis/blood
;
Tuberculosis, Pleural/*diagnosis/metabolism
6.Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer.
Ji Won KIM ; Youngil KOH ; Dong Wan KIM ; Yong Oon AHN ; Tae Min KIM ; Sae Won HAN ; Do Youn OH ; Se Hoon LEE ; Seock Ah IM ; Tae You KIM ; Dae Seog HEO ; Yung Jue BANG
Cancer Research and Treatment 2013;45(4):325-333
PURPOSE: Vascular endothelial growth factor (VEGF)-A, VEGF165b, interleukin (IL)-1beta, and transforming growth factor (TGF)-beta1 are known to influence tumor angiogenesis. Clinical implications of these cytokines need to be elucidated. MATERIALS AND METHODS: Using clinical data and baseline serum samples of 140 consecutive patients with advanced non-small cell lung cancer who received platinum-based combination chemotherapy, we investigated the association among serum cytokine levels, treatment outcomes, as well as leukocyte and platelet counts. RESULTS: The median age of patients was 64 years (range, 26 to 86 years). The male to female ratio was 104:36. High TGF-beta1 and IL-1beta levels were associated with shorter progression-free survival, and high VEGF-A and IL-1beta levels were associated with shorter overall survival in the univariate analysis. VEGF165b was not related to the treatment outcomes. Leukocytosis and thrombocytosis were associated with shorter overall survival. The multivariate analysis demonstrated that VEGF-A, IL-1beta, and leukocytosis were significant prognostic factors (p=0.0497, p=0.047, and p<0.001, respectively). Leukocytosis was not associated with recent pneumonia (p=0.937) and correlated with VEGF-A (p<0.001) and TGF-beta1 (p=0.020) levels. CONCLUSION: Serum VEGF-A, TGF-1beta, and IL-1beta levels, in addition to leukocyte and platelet counts, are shown to be associated with clinical outcomes. Leukocyte and platelet counts are correlated with serum VEGF-A and TGF-beta1 levels.
Blood Platelets
;
Carcinoma, Non-Small-Cell Lung*
;
Cytokines
;
Disease-Free Survival
;
Drug Therapy, Combination
;
Female
;
Humans
;
Interleukin-1beta
;
Interleukins
;
Leukocytes
;
Leukocytosis
;
Male
;
Multivariate Analysis
;
Platelet Count
;
Pneumonia
;
Thrombocytosis
;
Transforming Growth Factor beta1*
;
Transforming Growth Factors
;
Vascular Endothelial Growth Factor A*
7.Alterations of CD4+CXCR5+Tfh cells and its transcription regulatory factors in children with asthma.
Ya-Jie CUI ; Guo-Hong CHEN ; Jun-Ling WANG ; Lin MA ; Xiao-Ling GUO ; Jian-Xiang LIAO ; Cheng-Rong LI ; Guo-Bing WANG
Chinese Journal of Contemporary Pediatrics 2014;16(12):1215-1219
OBJECTIVETo study the alterations of follicular T helper cells (CD4(+)CXCR5(+)Tfh cells, Tfh) on circulating T lymphocytes in children with asthma, and to study the expression of transcription regulatory factors BCL-6 and BLIMP-1 mRNA.
METHODSSixty-four children with asthma and 25 healthy controls were enrolled in this study. On the basis of the disease, the children with asthma were classified into acute phase group (n=36) and remission phase group (n=28). The flow cytometry was used to detect the proportion of CD4(+)CXCR5(+)Tfh cells on CD4(+)T lymphocytes. Real-time PCR was performed to detect the levels of BCL-6 mRNA and BLIMP-1 mRNA. The double -antibody Sandwich ELISA was used to detect plasma concentrations of total IgE, IL-2, IL-6 and IL-21.
RESULTSThe proportion of CD4(+)CXCR5(+)Tfh cells was significantly higher in the acute group than in the control group and the remission group (P<0.05). Transcription levels of BCL-6 mRNA were significantly higher, while the inhibitory factors BLIMP-1 mRNA was significantly lower in the acute group than in the remission group and control group (P<0.05). The plasma concentration of IL-6 in the acute group increased significantly compared with the control group (P<0.05). Plasma concentrations of total IgE and IL-21 increased significantly, in contrast, plasma IL-2 concentration decreased significantly in the acute group, compared with the control group and the remission group (P<0.05). Correlation analysis showed that both IL-21 and IL-6 concentrations were positively correlated with the proportion of CD4(+)CXCR5(+)Tfh cells (r=0.76, r=0.46 respectively; P<0.05), while IL-2 level was negatively correlated with the proportion of Tfh cells (r=-0.68, P<0.05).
CONCLUSIONSThe abnormal proportion of CD4(+)CXCR5(+)Tfh cells might be involved in the immunological pathogenesis of acute asthma in children. The increased expression of BCL-6 mRNA and decreased expression of BLIMP-1 mRNA as well as the alterations of plasma total IgE, cytokines IL-2, IL-6 and IL-21 in microenvironment might be account for the increased proportion of CD4(+)CXCR5(+)Tfh cells in children with acute asthma.
Asthma ; immunology ; Child ; Child, Preschool ; DNA-Binding Proteins ; genetics ; Female ; Humans ; Immunoglobulin E ; blood ; Infant ; Interleukins ; blood ; Male ; Positive Regulatory Domain I-Binding Factor 1 ; Proto-Oncogene Proteins c-bcl-6 ; RNA, Messenger ; analysis ; Receptors, CXCR5 ; analysis ; Repressor Proteins ; genetics ; T-Lymphocytes, Helper-Inducer ; immunology